Pathophysiology of Childhood Hemolytic Uremic Syndrome
儿童溶血尿毒症综合征的病理生理学
基本信息
- 批准号:6922877
- 负责人:
- 金额:$ 38.53万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-02-01 至 2008-06-30
- 项目状态:已结题
- 来源:
- 关键词:Escherichia coli infectionsbacterial cytopathogenic effectbeta globulinchild (0-11)comorbiditycomplementdisease /disorder modeldisease /disorder prevention /controldisease /disorder proneness /riskearly diagnosisfibringenetic polymorphismgenetic susceptibilityhemolytic anemiahost organism interactionhuman genetic material taghuman subjectmodel design /developmentmolecular pathologynucleic acid sequencepathologic processpatient oriented researchpediatricsrenal failurethrombosisvascular endothelium
项目摘要
DESCRIPTION (provided by applicant): Escherichia coli O157:H7-associated
hemolytic uremic syndrome (HUS) remains a challenging medical problem.
Extensive thrombogenesis, with accompanying fibrinolysis inhibition, precede
the earliest indications of renal injury. Trends in thrombogenesis moreover
predict the severity of ensuing HUS. Presumably, a massive endothelial injury
before renal injury leads to HUS. This injury is amenable to study, and,
possibly, to the attenuation of its effects.
In this grant, the thrombogenic process in infected children will be studied
intensively. Specifically, we will test the hypotheses that thrombogenesis
clearly precedes renal injury, and that the rate of fibrin formation on initial
assessment of E. coli O157:H7 infections is associated with outcome (Aim 1). To
further assess the coagulation lesion, we will also test the hypotheses that
net interval accumulation of fibrin between the first and second day of
observation predicts outcome of this infection, and that time-dependent changes
in prothrombotic kinetics underlie the pathophysiologic cascade leading to the
development of HUS (Aim 2).
We will also use our unique population to test the hypotheses that (a) the
degree of activation of the complement system predicts outcome in children with
E. coli O157:H7 infection, and (b) one or more factor H gene polymorphisms is
associated with this outcome (Aim 3). Finally, because the endothelial cell is
likely to be critical in the evolution of HUS, we will test the hypothesis that
differences between the concentration of circulating endothelial cells in
infected children predict outcome. We shall also test the subsidiary hypothesis
that these cells express proteins plausibly related to their in situ injury or
activation (Aim 4).
A unique network has been assembled to identify children at risk of developing
HUS an average of three days before HUS develops. This is an inadequately
studied, but absolutely appropriate, model for toxin-related HUS. This network
will be amalgamated with investigative expertise in the fields of coagulation
assessment, complement pathophysiology and genetics, and endothelial cell
biology. The project seeks a more complete understanding of the cascade leading
to HUS, and, with this knowledge, the successful interdiction of this process.
描述(由申请人提供):大肠杆菌O157: h7相关
项目成果
期刊论文数量(15)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Escherichia coli O157 exposure in Wyoming and Seattle: serologic evidence of rural risk.
怀俄明州和西雅图的大肠杆菌 O157 暴露:农村风险的血清学证据。
- DOI:10.3201/eid0910.020254
- 发表时间:2003
- 期刊:
- 影响因子:11.8
- 作者:Haack,JasonP;Jelacic,Srdjan;Besser,ThomasE;Weinberger,Edward;Kirk,DonaldJ;McKee,GarryL;Harrison,ShannonM;Musgrave,KarlJ;Miller,Gayle;Price,ThomasH;Tarr,PhilipI
- 通讯作者:Tarr,PhilipI
Comparison of Escherichia coli O157:H7 antigen detection in stool and broth cultures to that in sorbitol-MacConkey agar stool cultures.
粪便和肉汤培养物中大肠杆菌 O157:H7 抗原检测与山梨糖醇-麦康凯琼脂粪便培养物中大肠杆菌 O157:H7 抗原检测的比较。
- DOI:10.1128/jcm.38.9.3404-3406.2000
- 发表时间:2000
- 期刊:
- 影响因子:9.4
- 作者:Stapp,JR;Jelacic,S;Yea,YL;Klein,EJ;Fischer,M;Clausen,CR;Qin,X;Swerdlow,DL;Tarr,PI
- 通讯作者:Tarr,PI
Thrombogenic alleles, Escherichia coli O157:H7 infections, and hemolytic uremic syndrome.
血栓形成等位基因、大肠杆菌 O157:H7 感染和溶血性尿毒症综合征。
- DOI:10.1097/00001721-200106000-00009
- 发表时间:2001
- 期刊:
- 影响因子:0
- 作者:Sprouse,JT;Wong,CS;Chandler,WL;Williams,GD;Watkins,SL;Tarr,PI
- 通讯作者:Tarr,PI
Platelet-activating factor and Escherichia coliO157:H7 infections.
血小板激活因子和大肠杆菌O157:H7 感染。
- DOI:10.1007/s00467-002-0970-7
- 发表时间:2002
- 期刊:
- 影响因子:0
- 作者:Smith,JodiM;Jones,Falaah;Ciol,MarciaA;Jelacic,Srdjan;Boster,DanielR;Watkins,SandraL;Williams,GlynD;Tarr,PhillipI;HendersonJr,WilliamR
- 通讯作者:HendersonJr,WilliamR
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PHILLIP I TARR其他文献
PHILLIP I TARR的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PHILLIP I TARR', 18)}}的其他基金
The Neonatal Microbiome and Necrotizing Enterocolitis
新生儿微生物组和坏死性小肠结肠炎
- 批准号:
8134250 - 财政年份:2009
- 资助金额:
$ 38.53万 - 项目类别:
The Neonatal Microbiome and Necrotizing Enterocolitis
新生儿微生物组和坏死性小肠结肠炎
- 批准号:
8318269 - 财政年份:2009
- 资助金额:
$ 38.53万 - 项目类别:
The Neonatal Microbiome and Necrotizing Enterocolitis
新生儿微生物组和坏死性小肠结肠炎
- 批准号:
7650793 - 财政年份:2009
- 资助金额:
$ 38.53万 - 项目类别:
The Neonatal Microbiome and Necrotizing Enterocolitis
新生儿微生物组和坏死性小肠结肠炎
- 批准号:
8111454 - 财政年份:2009
- 资助金额:
$ 38.53万 - 项目类别:
STRATEGIC TARGETING OF VIRAL GENOMES IN BILIARY ATRESIA
胆道闭锁中病毒基因组的策略性靶向
- 批准号:
7599257 - 财政年份:2008
- 资助金额:
$ 38.53万 - 项目类别:
THE GUT MICROBIOME IN DEVELOPMENT, HEALTH, AND DISEASE
肠道微生物组在发育、健康和疾病中的作用
- 批准号:
7614942 - 财政年份:2008
- 资助金额:
$ 38.53万 - 项目类别:
Pathophysiology of Childhood Hemolytic Uremic Syndrome
儿童溶血尿毒症综合征的病理生理学
- 批准号:
6972016 - 财政年份:2004
- 资助金额:
$ 38.53万 - 项目类别:
Pathophysiology of Childhood Hemolytic Uremic Syndrome
儿童溶血尿毒症综合征的病理生理学
- 批准号:
6613831 - 财政年份:2003
- 资助金额:
$ 38.53万 - 项目类别: